Shares of HLS Therapeutics Inc. (OTCMKTS:HLTRF – Get Free Report) shot up 2.2% during trading on Monday . The stock traded as high as $2.75 and last traded at $2.75. 202 shares were traded during mid-day trading, an increase of 0% from the average session volume of 201 shares. The stock had previously closed at $2.69.
HLS Therapeutics Trading Up 2.2 %
The firm has a fifty day simple moving average of $2.53 and a two-hundred day simple moving average of $2.50.
HLS Therapeutics Company Profile
HLS Therapeutics Inc, a specialty pharmaceutical company, acquires and commercializes pharmaceutical products in the specialty central nervous system and cardiovascular markets in Canada, the United States, and internationally. The company's product portfolio includes Clozaril, an atypical antipsychotic for management of symptoms of treatment-resistant schizophrenia; and Vascepa, an icosapent ethyl capsules for cardiovascular disease.
Further Reading
- Five stocks we like better than HLS Therapeutics
- What is a Stock Market Index and How Do You Use Them?
- Build-Your-Bowl Battle: CAVA, Chipotle, and Sweetgreen Face Off
- Technology Stocks Explained: Here’s What to Know About Tech
- Insiders Are Loading Up: 3 Key Stock Picks for Investors
- What is a Low P/E Ratio and What Does it Tell Investors?
- How Cigna Remains at the Top of the Health Insurance Food Chain
Receive News & Ratings for HLS Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HLS Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
